This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corporation, specifically its Exact Sciences Laboratories, LLC division, for the provision of Oncotype DX cancer testing services.
The BPA has a ceiling value of $900,925.40 and a period of performance from March 16, 2025 to March 15, 2026. Exact Sciences, which is the developer and manufacturer of the Cologuard colorectal cancer screening test, will provide gene expression profiling, genomic testing, and related laboratory services to support the VA's healthcare programs. This includes the provision of Oncotype DX testing for breast cancer patients under a separate $335,800 BPA awarded by VISN 17, as well as a $463,098 BPA from the Defense Health Agency for cancer testing referral laboratory services. Delivery orders issued under these IDVs have ranged from $41,447 to $701,268, demonstrating the specialized nature of the contracted cancer testing and diagnostic services.
Generated 1/30/25, 9:04 AM